Cytomegalovirus reactivation after autologous stem cell transplantation in multiple myeloma patients treated with novel agents.
Division of Hematology & Bone Marrow Transplantation, Max Superspeciality Hospital, New Delhi, India.
R
R
Naithani
Microbiology Department, Max Superspeciality Hospital, New Delhi, India.
B
B
Tarai
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000097:blood / Q000473:pathology* / Q000821:virology; D004279:DNA, Viral / Q000097:blood; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D000077562:Valganciclovir; D014766:Viremia
D000998:Antiviral Agents; D004279:DNA, Viral; D000077562:Valganciclovir; D015774:Ganciclovir
CMV; autologous stem cell transplantation; cytomegalovirus; multiple myeloma; myeloma